Drug-Resistant Tuberculosis, Georgia, Kazakhstan, Kyrgyzstan, Moldova, and Ukraine, 2017–2022

Details

• Alternative Title:
  Emerg Infect Dis
• Personal Author:
  Dahl, Victor Naestholt ; Butova, Tetiana ; Rosenthal, Alex ; Grinev, Alina ; Gabrielian, Andrei ; Vashakidze, Sergo ; Shubladze, Natalia ; Toxanbayeva, Bekzat ; Chingissova, Lyailya ; Crudu, Valeriu ; Chesov, Dumitru ; Kalmambetova, Gulmira ; Saparova, Gulbarchyn ; Wejse, Christian Morberg ; Butov, Dmytro
• Corporate Authors:
  Ukraine TB-Portal Study Group
• Description:
  In 2021, the World Health Organization recommended new extensively drug-resistant (XDR) and pre-XDR tuberculosis (TB) definitions. In a recent cohort of TB patients in Eastern Europe, we show that XDR TB as currently defined is associated with exceptionally poor treatment outcomes, considerably worse than for the former definition (31% vs. 54% treatment success).
• Subjects:
  Humans Tuberculosis, Multidrug-Resistant
• Keywords:
  Bacteria Biotechnology Books And Media Central Asia Disease Management Eastern Europe Epidemiology Extensively Drug-resistant Tuberculosis Georgia Kazakhstan Kyrgyzstan Mitochondrial RNA Moldova Multidrug-resistant Tuberculosis Treatment Outcome Tuberculosis And Other Mycobacteria Ukraine Vaccines

  More +
• Source:
  Emerg Infect Dis. 2024; 30(4):831-833
• Pubmed ID:
  38526186
• Pubmed Central ID:
  PMC10977852
• Document Type:
  Journal Article
• Genre:
  Research Letter
• Place as Subject:
  Ukraine ; Moldova ; Kazakhstan ; Kyrgyzstan ; Georgia (Republic)
• Volume:
  30
• Issue:
  4
• Collection(s):
  Emerging Infectious Diseases
• Main Document Checksum:
  urn:sha256:065e31aeeffbf3fac911f6a17146466f7beb7bd1c4b0f001cb64304bbf58ce43
• Download URL:
  https://stacks.cdc.gov/view/cdc/152977/cdc_152977_DS1.pdf
• File Type:
  [PDF - 714.49 KB ]